XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 4,244,871 $ 7,809,487
Contract and grants receivable 1,530,735 926,251
Prepaid expenses 122,898 263,254
Income tax receivable 416,810
Total current assets 5,898,504 9,415,802
Security deposit 22,734 22,734
Office furniture and equipment, net 30,210 37,163
Deferred offering costs 140,246
Intangible assets, net 60,445 73,952
Total assets 6,152,139 9,549,651
Current liabilities:    
Accounts payable 1,686,467 1,753,614
Accrued expenses 1,729,905 1,143,306
Deferred revenue 56,692
Accrued compensation 56,116 333,019
Total current liabilities 3,529,180 3,229,939
Commitments and contingencies
Shareholders' equity:    
Preferred stock, 350,000 shares authorized; none issued or outstanding
Common stock, $.001 par value; 25,000,000 shares authorized ; 8,750,801 shares and 8,730,640 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively 8,751 8,731
Additional paid-in capital 163,817,801 163,581,026
Accumulated deficit (161,203,593) (157,270,045)
Total shareholders' equity 2,622,959 6,319,712
Total liabilities and shareholders' equity $ 6,152,139 $ 9,549,651